Association of Breast Cancer in Men with Exposure to 5-Alpha Reductase Inhibitors: A RADAR Report
May 2012
in “
Journal of Clinical Oncology
”
TLDR Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.
Related Research
9 / 9 results
research Evaluation of the Therapeutic Effects of AGA Drugs by Measuring Finasteride, Dutasteride, and Dihydrotestosterone in Hair
Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.
research Change in Hair Growth-Related Gene Expression Profile in Human Isolated Hair Follicles Induced by 5-Alpha Reductase Inhibitors – Dutasteride and Finasteride – in the Presence of Testosterone
Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.
research 5-Alpha Reductase Inhibitors in Androgenetic Alopecia: Shifting Paradigms, Current Concepts, Comparative Efficacy, and Safety
Dutasteride works better than finasteride for hair loss, with both being safe to use.
research Luncheon Symposium: Update on the Efficacy and Safety of Dutasteride in the Management of Androgenetic Alopecia
Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.
research Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-Alpha Reductase Inhibitors
Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.
research An Overview on 5α-Reductase Inhibitors
5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.
research The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride
Dutasteride more effective for hair growth, but has more side effects than finasteride.
research The Benefits of Dual Inhibition of 5α Reductase
The document discussed the benefits of dual inhibition of 5α-reductase in managing benign prostatic hyperplasia (BPH), focusing on dutasteride, which inhibited both type I and type II 5α-reductase, leading to greater suppression of dihydrotestosterone (DHT) than finasteride, which only inhibited type II. In a study with 399 patients, dutasteride reduced DHT levels by 94.7% compared to 70.8% with finasteride and showed more rapid and significant improvements in symptoms and prostate volume reduction over 4 years. However, the document noted that direct comparative studies between dutasteride and finasteride were limited, leaving the question of definitive superiority unresolved.
research Effective Treatment of Female Androgenic Alopecia with Dutasteride
Dutasteride successfully treated a woman's hair loss when other treatments failed.